BELLEVUE, Wash.--(BUSINESS WIRE)--TranSenda International, LLC announced today that it is developing a new solution, Cortex, designed to improve an organization’s ability to manage a clinical trial’s performance. Based upon patent-pending ClinBUS® data interchange technology already in use in TranSenda’s Office-Smart solutions, Cortex will enable organizations to leverage the power of access to centralized operational data from all applications used across all clinical studies. For years the industry has struggled with an increasingly fragmented environment of disconnected clinical applications, sites and partners. TranSenda’s Cortex, with its proven ClinBUS technology, represents a breakthrough in managing and controlling studies within a common environment—independent of study data formats and clinical trial applications.
